首页>
外国专利>
OBTAINING GENE-ENGINEERING T-CELLS BY MEANS OF THE SLEEPING BEAUTY TRANSPOSE IN COMBINATION WITH SELECTION OF METOTREXATE
OBTAINING GENE-ENGINEERING T-CELLS BY MEANS OF THE SLEEPING BEAUTY TRANSPOSE IN COMBINATION WITH SELECTION OF METOTREXATE
展开▼
机译:睡美人转膜结合甲氨蝶呤的选择获得基因工程T细胞
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides nucleic acids, vectors, host cells, methods and compositions to confer and/or augment immune responses mediated by cellular immunotherapy, such as by adoptively transferring CD8+ central memory T cells or combinations of central memory T cells with CD4+ T cells that are genetically modified to express a chimeric receptor. In some alternatives the genetically modified host cell comprises a nucleic acid comprising a polynucleotide coding for a ligand binding domain, a poly nucleotide comprising a customized spacer region, a polynucleotide comprising a transmembrane domain, and a polynucleotide comprising an intracellular signaling domain. In some alternatives, the ligand binding domains binds to CD171.
展开▼